Active-ingredient Dossier
Liraglutide
Active-ingredient Dossier for Liraglutide (glucagon-like peptide-1 receptor agonist). Australian brands, products, PBS listings, PBAC outcomes — compiled…
- Brand: VICTOZA
- Brand: SAXENDA
- Brand: ARX-LIRAGLUTIDE
- Brand: LIRAGLUTIDE
- Brand: LIRAGLUTIDE
- Brand: LOBEZYL
- Therapeutic area: Endocrinology
What is
Liraglutide Liraglutide is a glucagon-like peptide-1 receptor agonist.
Australian brands containing
Liraglutide — VICTOZA — SAXENDA — LIRAGLUTIDE — ARX-LIRAGLUTIDE — LOBEZYL — BENEDO
Therapeutic areas
Liraglutide is registered in endocrinology (4 brands) and cardiology (4 brands).
Sponsor landscape
Liraglutide is marketed by four sponsors: Cipla, Sun Pharma, Taevas Life Sciences, and Novo Nordisk Pharmaceuticals.
PBS and regulatory activity
Two brands have PBAC outcomes on record, with the latest PBAC outcome dated 1 July 2021. Two brands have AusPARs on record, with the latest AusPAR dated 23 December 2015.